AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER

被引：0
|
作者：
Gerardi, C. [1 ]
Floriani, I. [1 ]
Biagioli, E. [1 ]
D'Incalci, M. [1 ]
Fossati, R. [1 ]
Colombo, N. [2 ]
机构：
[1] IRCCS Ist Ric Farmacol Mario Negri Milano, Milan, Italy
[2] Univ Milano Bicocca, Dipartimento Sci Chirurg, Milan, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-1249
引用
收藏
页码：455 / 456
页数：2
相关论文
共 50 条
  • [41] NICE guidance on bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer
    Pinilla-Dominguez, Pilar
    Richardson, Joanna
    Robertson, Janet
    Adam, Jane
    LANCET ONCOLOGY, 2013, 14 (08): : 691 - 692
  • [42] Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
    Zivanovic, Oliver
    Chi, Dennis S.
    Zhou, Qin
    Iasonos, Alexia
    Konner, Jason A.
    Makker, Vicky
    Grisham, Rachel N.
    Brown, Amy K.
    Nerenstone, Stacy
    Diaz, John P.
    Schroeder, Eric D.
    Langstraat, Carrie L.
    Paroder, Viktoriya
    Lakhman, Yulia
    Soldan, Krysten
    Su, Katy
    Gardner, Ginger J.
    Andikyan, Vaagn
    Guo, Jianxia
    Jewell, Elizabeth L.
    Roche, Kara Long
    Troso-Sandoval, Tiffany
    Lichtman, Stuart M.
    Moukarzel, Lea A.
    Dessources, Kimberly
    Abu-Rustum, Nadeem R.
    Aghajanian, Carol
    Tew, William P.
    Beumer, Jan
    Sonoda, Yukio
    O'Cearbhaill, Roisin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (23) : 2594 - +
  • [43] Phase I pharmacology study of carboplatin and weekly paclitaxel in platinum-sensitive ovarian cancer patients with recurrent disease
    Aghajanian, C
    Sabbatini, P
    Hensley, M
    Spriggs, D
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 42 - 42
  • [44] A phase II nonrandomized study of nab-paclitaxel plus carboplatin in patients with recurrent platinum-sensitive ovarian or primary peritoneal cancer
    Benigno, B. B.
    Burrell, M. O.
    Daugherty, P.
    Hernandez, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer
    del Carmen, Marcela G.
    Micha, John
    Small, Laurie
    Street, Daron G.
    Londhe, Anil
    McGowan, Tracy
    GYNECOLOGIC ONCOLOGY, 2012, 126 (03) : 369 - 374
  • [46] Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
    Pfisterer, Jacobus
    Shannon, Catherine M.
    Baumann, Klaus
    Rau, Joern
    Harter, Philipp
    Joly, Florence
    Sehouli, Jalid
    Canzler, Ulrich
    Schmalfeldt, Barbara
    Dean, Andrew P.
    Hein, Alexander
    Zeimet, Alain G.
    Hanker, Lars C.
    Petit, Thierry
    Marme, Frederik
    El-Balat, Ahmed
    Glasspool, Rosalind
    de Gregorio, Nikolaus
    Mahner, Sven
    Meniawy, Tarek M.
    Park-Simon, Tjoung-Won
    Mouret-Reynier, Marie-Ange
    Costan, Cristina
    Meier, Werner
    Reinthaller, Alexander
    Goh, Jeffrey C.
    L'Haridon, Tifenn
    Hay, Sally Baron
    Kommoss, Stefan
    du Bois, Andreas
    Kurtz, Jean-Emmanuel
    LANCET ONCOLOGY, 2020, 21 (05): : 699 - 709
  • [47] Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent platinum-sensitive ovarian cancer
    Ferrandina, G
    Ludovisi, M
    Dagostino, G
    Lorusso, D
    Naldini, A
    Testa, AC
    Paris, I
    Gallotta, V
    Pozzo, C
    Scambia, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 468S - 468S
  • [48] A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG)
    Pujade-Lauraine, E.
    Mahner, S.
    Kaern, J.
    Gebski, V.
    Heywood, M.
    Vasey, P.
    Reinthaller, A.
    Vergote, I.
    Pignata, S.
    Ferrero, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [49] A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG)
    Wagner, U.
    Burges, A.
    Kurzeder, C.
    Beckmann, M. W.
    Belau, A.
    Hanker, L.
    Canzler, U.
    Richter, B.
    Sehouli, J.
    Pujade-Lauraine, E.
    ONKOLOGIE, 2010, 33 : 2 - 2
  • [50] A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer
    Blumenschein, G. R., Jr.
    Kabbinavar, F.
    Menon, H.
    Mok, T. S. K.
    Stephenson, J.
    Beck, J. T.
    Lakshmaiah, K.
    Reckamp, K.
    Hei, Y. -J.
    Kracht, K.
    Sun, Y. -N.
    Sikorski, R.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2011, 22 (09) : 2057 - 2067
12345